EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY

Alia Rahman, Fajriah Azra

Jurnal Crystal : Publikasi Penelitian Kimia dan Terapannya · 30.09.2026 · 8 (2) · 273-287

DOI: 10.36526/jc.v8i2.7201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Crystal : Publikasi Penelitian Kimia dan Terapannya, online erschienen am 30.09.2026. Verfasst von Alia Rahman und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HER2 is a tyrosine kinase receptor involved in cell proliferation, differentiation, and survival. Its overexpression promotes cancer progression and therapeutic resistance, indicating the need for new HER2 inhibitors. In this study, twelve 1,2,3-triazolo-indole-2-carboxylate derivatives were evaluated as potential HER2 inhibitors using in silico approaches. Drug-likeness was analyzed using SwissADME, ADMET properties were predicted with pkCSM, and molecular docking was performed using MOE. Docking analysis indicated that several compounds exhibited strong binding affinity toward HER2, with compounds 6b, 6c, 6d, 6e, and 9a identified as the most promising candidates. Among them, compound 6d showed the most balanced profile, combining strong binding affinity, favorable interactions comparable to lapatinib, moderate aqueous solubility, high Caco-2 permeability, non-substrate behavior toward P-gp, and non-mutagenic properties. ADMET evaluation revealed that all compounds complied with Lipinski’s rule and exhibited high total clearance. However, limitations were observed in distribution parameters (VDss, Fu, and BBB), potential hepatotoxicity, and inhibition of several CYP enzymes, except CYP2D6. Overall, compound 6d is proposed as a promising HER2 inhibitor candidate, although further in vitro and in vivo validation is required to improve safety and pharmacokinetic profiles.

Zitieren

APA

Rahman, A., & Azra, F. (2026). DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY. Jurnal Crystal : Publikasi Penelitian Kimia dan Terapannya, 8(2), 273-287. https://doi.org/10.36526/jc.v8i2.7201

Vancouver

Rahman A, Azra F. DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY. Jurnal Crystal : Publikasi Penelitian Kimia dan Terapannya. 2026;8(2):273-287. doi:10.36526/jc.v8i2.7201

BibTeX
@article{Rahman2026,
  author = {Rahman, Alia and Azra, Fajriah},
  title = {DOCKING SIMULATION OF 1,2,3-TRIAZOLO-INDOLE-2-CARBOXYLATE DERIVATIVES AS POTENTIAL HER2 INHIBITORS FOR BREAST CANCER THERAPY},
  journal = {Jurnal Crystal : Publikasi Penelitian Kimia dan Terapannya},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {273--287},
  doi = {10.36526/jc.v8i2.7201}
}
Kostenlos starten →